DABITOR 150

DABITOR 150 contains Dabigatran Etexilate 150 mg, an oral anticoagulant that directly inhibits thrombin, preventing the formation of blood clots. It is primarily prescribed to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Additionally, it is used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), especially following orthopedic surgeries such as hip or knee replacement.

Key Features:

• Each capsule contains Dabigatran Etexilate 150 mg

• Direct thrombin inhibitor for effective anticoagulation

• Helps prevent stroke and systemic embolism in atrial fibrillation patients

• Effective in treating and preventing DVT and PE

• Oral administration with predictable anticoagulant effect